Lanreotide Acetate has 7 known drug interactions based on U.S. FDA drug labeling data. Notable interactions include combinations with Bromocriptine, Cyclosporine, Insulin Human. Patients taking Lanreotide Acetate should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 7
- Moderate
- 6
Moderate (6)
- Lanreotide Acetate + Bromocriptine— Concomitant administration may increase the absorption of bromocriptine.
- Lanreotide Acetate + Cyclosporine— Lanreotide may decrease the absorption of cyclosporine, necessitating dosage adjustment to maintain therapeutic concentr…
- Lanreotide Acetate + Insulin Human— Lanreotide inhibits insulin secretion; blood glucose monitoring and antidiabetic treatment adjustment are recommended.
- Lanreotide Acetate + Nonselective Beta-Adrenergic Antagonists— Lanreotide may have additive effects with bradycardia-inducing drugs, reducing heart rate; dosage adjustment may be nece…
- Lanreotide Acetate + Quinidine— Lanreotide may decrease metabolic clearance of quinidine; avoid concomitant use or consider dose reduction.
- Lanreotide Acetate + Terfenadine— Lanreotide may decrease metabolic clearance of terfenadine; avoid concomitant use or consider dose reduction.